Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

Biologics share of total drug costs in Canada by public drug plan 2017/2018

In fiscal year 2017/2018, the share of biologics of total drug cost in Nova Scotia's public drug plan amounted to 24.6 percent. This statistic depicts the biologic share of total drug costs in selected Canadian public drug plans in FY 2017/2018.

Biologic share of total drug costs in select Canadian public drug plans in 2017/2018

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

Canada

Survey time period

fiscal year 2017/2018

Supplementary notes

This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Canadian pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.